Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, et al. An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol. 2017;198(2):329–34. https://doi.org/10.1016/j.juro.2017.01.103.
Google Scholar
Lightner DJ, Wymer K, Sanchez J, Kavoussi L. Best practice statement on urologic procedures and antimicrobial prophylaxis. J Urol. 2020;203(2):351–6. https://doi.org/10.1097/ju.0000000000000509.
Google Scholar
Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, et al. The incidence of fluoroquinolone-resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol. 2008;179(3):952–5. https://doi.org/10.1016/j.juro.2007.10.071.
Google Scholar
Kherroubi L, Bacon J, Rahman KM. Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation. JAC Antimicrob Resist. 2024;6(4):dlae127. https://doi.org/10.1093/jacamr/dlae127.
Google Scholar
Liss MA, Taylor SA, Batura D, Steensels D, Chayakulkeeree M, Soenens C, et al. Fluoroquinolone-resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol. 2014;192(6):1673–8. https://doi.org/10.1016/j.juro.2014.06.005.
Google Scholar
Taylor S, Margolick J, Abughosh Z, Goldenberg SL, Lange D, Bowie WR, et al. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound-guided prostate biopsy. BJU Int. 2013;111(6):946–53. https://doi.org/10.1111/j.1464-410X.2012.11637.x.
Google Scholar
Batura D, Rao GG, Nielsen PB. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int. 2010;106(7):1017–20. https://doi.org/10.1111/j.1464-410X.2010.09294.x.
Google Scholar
Mann M, Calio BP, Mark JR, Chelluri R, Hufnagel E, Reese A, et al. Hospital-specific antibiograms and antibiotic prophylaxis for prostate biopsies: a reexamination of AUA recommendations. Can J Urol. 2020;27(1):10099–104.
Google Scholar
Rourke E, Madsen S, Yunes A, Basler J, Liss MA. Local antibiogram predicts appropriate antibiotic selection for prostate biopsy prophylaxis. Urol Pr. 2019;6(2):100–6. https://doi.org/10.1016/j.urpr.2018.06.003.
Google Scholar
Son KC, Chung HS, Jung SI, Kim MS, Hwang EC, Kim JW, et al. Trial comparing a combined regimen of amikacin and ciprofloxacin to ciprofloxacin alone as transrectal prostate biopsy prophylaxis in the era of high fluoroquinolone-resistant rectal flora. J Korean Med Sci. 2018;33(15):e113. https://doi.org/10.3346/jkms.2018.33.e113.
Google Scholar
Tsu JH, Ma WK, Chan WK, Lam BH, To KC, To WK, et al. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy. Urology. 2015;85(1):15–21. https://doi.org/10.1016/j.urology.2014.07.078.
Google Scholar
Kim JB, Jung SI, Hwang EC, Kwon DD. Prevalence of antibiotic-resistant bacteria on rectal swabs and factors affecting resistance to antibiotics in patients undergoing prostate biopsy. Korean J Urol. 2014;55(3):201–6. https://doi.org/10.4111/kju.2014.55.3.201.
Google Scholar
Singh P, Kumar A, Yadav S, Prakash L, Nayak B, Kumar R, et al. Targeted” prophylaxis: impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy. Investig Clin Urol. 2017;58(5):365–70. https://doi.org/10.4111/icu.2017.58.5.365.
Google Scholar
Liss MA, Chang A, Santos R, Nakama-Peeples A, Peterson EM, Osann K, et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol. 2011;185(4):1283–8. https://doi.org/10.1016/j.juro.2010.11.088.
Google Scholar
Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol. 2012;187(4):1275–9. https://doi.org/10.1016/j.juro.2011.11.115.
Google Scholar
Tops SCM, Kolwijck E, Koldewijn EL, Somford DM, Delaere FJM, van Leeuwen MA, et al. Rectal culture-based versus empirical antibiotic prophylaxis to prevent infectious complications in men undergoing transrectal prostate biopsy: a randomized, nonblinded multicenter trial. Clin Infect Dis. 2022;76(7):1188–96. https://doi.org/10.1093/cid/ciac913.
Google Scholar
Hu JC, Assel M, Allaf ME, Vickers AJ, Ehdaie B, Cohen AJ, et al. Transperineal vs transrectal prostate biopsy—the PREVENT randomized clinical trial. JAMA Oncol. 2024;10(11):1590–3. https://doi.org/10.1001/jamaoncol.2024.4000.
Google Scholar
Hu J, Zhu A, Vickers A, Allaf ME, Ehdaie B, Schaeffer A, et al. Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectious complications. BMJ Open. 2023;13(5):e071191 https://doi.org/10.1136/bmjopen-2022-071191.
Google Scholar
Hu JC, Assel M, Allaf ME, Ehdaie B, Vickers AJ, Cohen AJ, et al. Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial. Eur Urol. 2024;86(1):61–8. https://doi.org/10.1016/j.eururo.2023.12.015.
Google Scholar
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https://doi.org/10.1016/j.jbi.2019.103208.
Google Scholar
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. https://doi.org/10.1016/j.jbi.2008.08.010.
Google Scholar
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.
Google Scholar
R Development Core Team. R: a language and environment for statistical computing. R version 4.3.2 ed. Vienna, Austria: R Foundation for Statistical Computing; 2023.
Shoag JE, Gaffney C, Pantuck M, Sun T, Gorin M, Schaeffer E, et al. Risk factors for infection after prostate biopsy in the United States. Urology. 2020;138:113–8. https://doi.org/10.1016/j.urology.2019.12.023.
Google Scholar
Bidell MR, Palchak M, Mohr J, Lodise TP. Fluoroquinolone and third-generation-cephalosporin resistance among hospitalized patients with urinary tract infections due to Escherichia coli: do rates vary by hospital characteristics and geographic region?. Antimicrob Agents Chemother. 2016;60(5):3170–3. https://doi.org/10.1128/aac.02505-15.
Google Scholar
Augostini A, Wattengel BA, Mergenhagen KA. An evaluation of antimicrobial prophylaxis for transrectal prostate biopsies: A potential stewardship target. Am J Infect Control. 2024;52(10):1184–7. https://doi.org/10.1016/j.ajic.2024.05.012.
Google Scholar
Balasubramanian A, Wald G, Rhodes S, Gurayah A, Arenas-Gallo C, Millot J, et al. Incidence and prevention strategies for postprostate biopsy infections in the United States from 2012 to 2021. Urol Oncol: Semin Orig Investig. 2025;43(9):527.e1–e8. https://doi.org/10.1016/j.urolonc.2025.05.005.
Google Scholar
Tan WP, Papagiannopoulos D, Latchamsetty KC, Wilson N, O’Block N, Raff L, et al. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy. Prostate Cancer Prostatic Dis. 2019;22(2):268–75. https://doi.org/10.1038/s41391-018-0092-3.
Google Scholar
Suzuki H, Perencevich EN, Livorsi DJ, Alexander B, Beck BF, Richardson KK, et al. Attributable mortality due to fluoroquinolone and extended-spectrum cephalosporin resistance in hospital-onset Escherichia coli and Klebsiella spp bacteremia: a matched cohort study in 129 Veterans Health Administration medical centers. Infect Control Hosp Epidemiol. 2019;40(8):928–31. https://doi.org/10.1017/ice.2019.155.
Google Scholar
Grigoryan L, Germanos G, Zoorob R, Juneja S, Raphael JL, Paasche-Orlow MK, et al. Use of antibiotics without a prescription in the U.S. Population. Ann Intern Med. 2019;171(4):257–63. https://doi.org/10.7326/M19-0505.
Google Scholar
See I, Wesson P, Gualandi N, Dumyati G, Harrison LH, Lesher L, et al. Socioeconomic factors explain racial disparities in invasive community-associated methicillin-resistant Staphylococcus aureus disease rates. Clin Infect Dis. 2017;64(5):597–604. https://doi.org/10.1093/cid/ciw808.
Google Scholar
Roberts MJ, Williamson DA, Hadway P, Doi SAR, Gardiner RA, Paterson DL. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. Int J Antimicrob Agents. 2014;43(4):301–9. https://doi.org/10.1016/j.ijantimicag.2014.01.008.
Google Scholar
Cohen JE, Landis P, Trock BJ, Patel HD, Ball MW, Auwaerter PG, et al. Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis. J Urol. 2015;193(2):552–6. https://doi.org/10.1016/j.juro.2014.08.008.
Google Scholar
Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, et al. Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches. Urology. 2017;104:11–21.
Google Scholar
U. S. Census Bureau. DEC Redistricting Data (PL 94-171) RACE. Decennial Census; 2020.
Rosario DJ, Lane JA, Metcalfe C, Donovan JL, Doble A, Goodwin L, et al. Short-term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ. 2012;344:d7894 https://doi.org/10.1136/bmj.d7894.
Google Scholar
